Evidence map›Paper›PMID 21243036›Full record

ArticleDrug discovery today. Technologies2010

Epigenetics: Tools and Technologies.

William P Janzen, Tim J Wigle, Jian Jin, Stephen V Frye

Open access · greenAbstract read
In one paragraph

Article in Drug discovery today. Technologies, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. The computational power of the human brain.Frontiers in cellular neuroscience · 2023
    Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Epigenetics and autism spectrum disorder: A report of an autism case with mutation in H1 linker histone HIST1H1E and literature review.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2018
    Review
  14. Review
  15. Computer-aided Molecular Design of Compounds Targeting Histone Modifying Enzymes.Computational and structural biotechnology journal · 2015
    Review
  16. A TR-FRET-based functional assay for screening activators of CARM1.Chembiochem : a European journal of chemical biology · 2013
    Article
  17. LSD1/CoREST is an allosteric nanoscale clamp regulated by H3-histone-tail molecular recognition.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

William P JanzenThe Center for Integrative Chemical Biology and Drug Discovery, The University of North Carolina at Chapel Hill, Genetics Medicine Building, Campus Box 7363, Chapel Hill, NC 27599-7363, USA.
Tim J Wigle
Jian Jin
Stephen V Frye
University of North Carolina at Chapel Hill · US

Funding

Discovery of Small Molecule MBT Domain AntagonistsRC1GM090732 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FRYE, STEPHEN VERNON · 2009 to 2010
$876k
NIGMS NIH HHS RC1 GM090732
6 · The paper itself

Abstract

Epigenetics refers to heritable changes that control how the genome is accessed in different cell-types and during development and differentiation. Even though each cell contains essentially the same genetic code, epigenetic mechanisms permit specialization of function between cells. The state of chromatin, the complex of histone proteins, RNA and DNA that efficiently package the genome, is largely regulated by specific modifications to histone proteins and DNA, and the recognition of these marks by other proteins and protein complexes. The enzymes that produce these modifications (the 'writers'), the proteins that recognize them (the 'readers'), and the enzymes that remove them (the 'erasers') are critical targets for manipulation in order to further understand the histone code and its role in biology and human disease.

Identifiers

PMID21243036
PMCPMC3018755
OpenAlexW2164044577

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.